检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]新疆维吾尔自治区人民医院检验科,乌鲁木齐830001
出 处:《国际检验医学杂志》2011年第2期194-195,共2页International Journal of Laboratory Medicine
摘 要:目的观察慢性乙型肝炎病毒(HBV)感染者不同临床期免疫球蛋白、T淋巴细胞亚群特征,探讨慢性HBV感染病情发展与机体细胞、体液免疫之间关系的变化规律。方法2007~2009年慢性HBV不同临床时期感染者71例,其中,轻、中度慢性乙型肝炎32例,肝炎后肝硬化代偿期21例,肝炎后肝硬化失代偿期18例,并以20例健康人作为健康对照组,检测免疫球蛋白、T淋巴细胞亚群等。结果肝炎后肝硬化代偿期和失代偿期患者外周血中CD3+T、CD4+T、CD8+T淋巴细胞少于慢性乙肝(轻中度)患者和健康对照组,差异具有统计学意义(P〈0.05);代偿期与失代偿期患者间、慢性乙肝(轻中度)患者与健康对照组间差异无统计学意义(P〉0.05)。慢性乙肝(轻中度)、肝炎后肝硬化代偿期和失代偿期患者7球蛋白均高于健康对照组(P〈0.05),代偿期与失代偿期间患者差异具有统计学意义(P〈0.05);清蛋白则肝炎后肝硬化代偿期和失代偿期患者显著低于慢性乙肝(轻中度)患者和健康对照组(P〈0.05),代偿期与失代偿期患者间差异具有统计学意义(P〈0.05),慢性乙肝(轻中度)患者与健康对照组间差异无统计学意义(P〉O.05);肝炎后肝硬化代偿期和失代偿期患者IgG、IgA均显著高于慢性乙肝(轻中度)患者和健康对照组(P〈0.05),代偿期与失代偿期患者间、慢性乙肝(轻中度)患者与健康对照组间差异无统计学意义(P〉0.05)。各组间IgM差异无统计学意义(P〉0.05)。结论慢性HBV感染者随着病情不断进展,细胞、体液免疫功能均不同程度受累。Objective To study the characteristic of immunoglobulin and peripheral blood T ceils subsets in patients with chron- ic hepatitis B. Methods Seventy-one patients with different stages of chronic hepatitis'B from 2007 to 2009,32 hepatitis B patients with gentle/mild chronic hepatitis B,21 with compensated liver cirrhosis, 18 with decompensated liver cirrhosis and 20 healthy controls were enrolled for observation. The peripheral blood T cells subsets, IgG, IgM, IgA,γ immunoglobulin and albumin were determined. Results The percentage of CD3+ ,CD4+ ,CD8+ T cells in compensated and decompensated liver cirrhosis were lower than in gentle/mild chronic hepatitis B and Control,the difference were significant(P〈0.05). The differences between gentle/mild chronic hepatitis B and control,compensated and decompensated liver cirrhosis were unsignificant(P〉0.05). 7 immunogl6bulin in gentle/ mild chronic hepatitis B, compensated and decompensated liver cirrhosis were significantly higher than control(P~ 0. 05). The difference between gentle/mild chronic hepatitis B and compensated/decompensated liver cirrhosis, compensated and decompensated liver cirrhosis was significant(P〈0.05). Albumin in compensated and decompensated liver cirrhosis was significantly lower than in gentle/mild chronic hepatitis B and control(P〈0.05). The di.fference between compensated and decompensated liver cirrhosis was significant(P〈0.05). IgG,IgA in compensated and decompensated liver cirrhosis were higher than gentle/mild chronic hepatitis B and control(P〈0.05). No significant difference on IgM in groups(P〉0.05)were observsed. Conclusion Cellular and humoral im- mune function were involved in chronic hepatitis B patients which correlated with disease progress.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.3